Qatar Biobank

Qatar Biobank is a research initiative that links the research community with the people of Qatar. We are a unique resource that will raise Qatar’s profile in biomedical research regionally and globally.

Qatar Biobank Population-Based Study

The Qatar Biobank Population Cohort study is the first and longest running study aiming to collect high-quality biological samples and annotated data for 60,000 participants from Qataris and long-term Qatar residents who live in Qatar for at least 15 years (age ≥ 18 years) to promote medical research in Qatar and worldwide.

To find out if you are eligible to participate, please look at the criteria below.

Eligibility Criteria:

• Qatari National

• Long-term resident of 15 years or more

• Over the age of 18

What Will Participating Involve?

• Having a series of measurements, such as height, weight, grip strength, blood pressure, body composition, heart and lung function.

• Giving samples of blood (about 60 milliliters, or around the same volume as a pocket-sized hand-sanitizer gel), urine, and saliva. All tests are entirely optional, and you can opt out at any point.

• Completing a questionnaire and provide some overall feedback on your experience at Qatar Biobank.

• Having a MRI scan for the whole body and brain during the second visit.

• Participants are entitled to a follow-up visit after five years.

If you're interested in participating, please register using the link, call us at 4454 1177, or email qphi@qf.org.qa

For detailed information on the tests involved, please click the link to learn more

Genetic Fragile Fracture

This genetic study aims to look at gene variants associated with fragility hip fracture and compression vertebral fracture in the Qatari and Arab population.

Eligibility Criteria

• Patients who have sustained fragility hip fracture and compression vertebral fracture.

• Recruitment through osteoporosis database of rheumatology division of Hamad Medical Corporation.

Cystic Fibrosis - CF Omics 

This is a nested study that aims to identify SARSCoV-2 resistance factors within Cystic Fibrosis patients in the Gulf Region

Eligibility Criteria

• Clinical diagnosis of Cystic Fibrosis 

• Recruitment into this study will be via pulmonary and chest clinics at Hamad General Hospital 

Qatar Cardiovascular Biorepository   Atrial- Fibrillation QCBio

The QCBio study is a disease-based study for people who have a clinical diagnosis of atrial fibrillation and their family members.

Eligibility Criteria

• Qatari National or GCC national

• Over the age of 18

• Atrial Fibrillation (AF) diagnosis or early onset 

• You are a relative to a person who is diagnosed with Atrial Fibrillation already registered in this study.

If you're interested in participating, please register using the link, call us at 4454 1177, or email qphi@qf.org.qa

COVID 19 Biorepository 

The COVID-19 Biorepository is a National Disease-based study aiming to collect adequate health information and biological samples of 6,000 participants to enable evidence-based research towards the discovery and development of novel healthcare interventions and to facilitate research projects related to the COVID-19 pandemic.

The COVID 19 biorepository was established at the start of the pandemic and has 2 arms.  

• The disease arm for participants with a confirmed positive laboratory diagnostic test of for COVID 19

• The vaccination arm for participants who are about to receive their COVID 19 vaccination, this arm recruited participants who had previously had a positive COVID 19 diagnosis and those who had never been diagnosed.

This study is currently not admitting new participants.

Qatar Twin Biorepository 

The aim of the Qatar Twin Biorepository is to help to understand the inheritance of complex diseases such as obesity, diabetes, and cardiovascular conditions.

Eligibility Criteria

• Qatari or resident twins (Children or Adults)

• Family members of twins (Children or Adults)

• Arabic or English speakers

If you're interested in participating, please register using the link, call us at 4454 1177, or email Qatartwinregistry@gmail.com 

Qatar Birth Cohort Study

The Qatari Birth Cohort study is the first mother-child cohort study in the Gulf that aims to assess the synergetic role of environmental exposure and genetic factors in the development of chronic diseases. The aim is to follow up 3,000 women during their pregnancy, at delivery and then follow up their children and father (triads: Mother-Child-Father) for a period of 5 years.

What is the purpose of this research?

This is a birth cohort epidemiological study where we prospectively observe women during their pregnancy, their children, and we also collect data from the father so as to determine the genetic and life-course influences on childhood health, development and/or common complex diseases development that may persist in adulthood. Therefore, the aim of the Qatar Birth Cohort project is to assess the synergetic role of environmental exposures and genetic factors in the development of chronic disease of woman and child health and/or obstetric characteristics with high prevalence in the state of Qatar. All the information we are going to collect will help us understand the causes of illness, which will help us to develop better ways of improving health and wellbeing.

Eligibility Criteria

• Pregnant Qatari National female and their husband

• Pregnant long-term resident of 15 years or more and their husband

If you're interested in participating, please register using the link, call us at 4454 1177, or email qphi@qf.org.qa